POMPANO BEACH, Fla., Nov. 16, 2006 (PRIMEZONE) -- MEDirect Latino Inc. (Pink Sheets:MLTO) (www.medirectlatino.org), the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community, today announced an investor conference call to be held on Thursday, November 16, 2006 at 4:15 p.m. Eastern Standard Time.
MEDirect Latino's Chairman and EVP, Raymond Talarico, will host the call. In attendance will be President and CEO, Ms. Debra L. Towsley, COO, Mr. Charles W. Hansen and Senior Accountant, Mr. William Moses; who will be making presentations on various aspects of the Company's 10K filing, and certain recent events.
"The management of the Company has been focused on making all SEC filings necessary to upgrade our listing status, as well as pursuing strategies to create immediate shareholder value," stated Raymond Talarico, Executive Vice-President and Chairman of the Company. "We have a commitment to our shareholders, as well as the investment community, for maximum disclosure and communication. We believe a thorough discussion of our 10K, as well as other recent significant positive corporate developments is needed at this time."
Instructions for hearing the conference call:
To hear the conference call as it takes place:
Call 1-800-434-1335 in the United States or Canada or;
Call 1-404-920-6442 in the Atlanta Area or Internationally
Pin Code: 43993739 followed by the pound sign
About MEDirect Latino:
MEDirect Latino (Pink Sheets:MLTO) (www.medirectlatino.org) is the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community. MEDirect Latino is rapidly growing and uniquely positioned to service the Hispanic community in the United States and Puerto Rico. MEDirect is the only company currently positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. Type II diabetes was targeted because of its unique status within the Medicare reimbursement regime and due to its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These and other conditions represent considerable future market potential, MEDirect will scale its model by leveraging its existing client base and infrastructure in introducing new products and services to existing customers as they are identified.
The MEDirect Latino Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=1873
Safe Harbor Disclosure
This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.